A study involving over 46 million adults in England shows COVID vaccines significantly reduce the risk of cardiovascular events, such as heart attacks and strokes. Despite a slight increase in myocarditis risk, the benefits of vaccination outweigh these minor risks,… Read More »COVID vaccines reduce the risk of heart attacks and strokes
Moderna’s phase 3 data for the mRNA-1083 combination COVID/flu vaccine showed higher immune responses against influenza and COVID compared to GSK’s and Sanofi’s vaccines. The study involved roughly 8,000 participants, split into two age groups. Results indicate significant effectiveness, targeting… Read More »Moderna COVID flu vaccine superior to separate vaccines in trial
A new study has been published that showed a small seizure safety signal in young children after receiving the Pfizer and Moderna COVID vaccines.
Recent long-term clinical trial data reveals the personalized mRNA vaccine, cevumeran, elicits a lasting immune response in pancreatic cancer patients, significantly improving recurrence-free survival. The phase 2 trial explores cevumeran’s combined efficacy with chemotherapy, as this approach shows potential to… Read More »mRNA vaccine for pancreatic cancer — excellent long-term results
A new personalized mRNA vaccine for pancreatic cancer, cevumeran, has shown promise in a phase 1 trial and is advancing to a larger phase 2 trial. It works by inducing an immune response against specific antigens in each patient’s tumor,… Read More »New mRNA vaccine for pancreatic cancer enters phase 2 trials
Early results have been reported for the new combination COVID-19 and flu vaccines are under development by Pfizer-BioNTech and Moderna.
The FDA has approved new COVID-19 booster vaccines that better target Omicron variants and subvariants. Recommended for six months and older.
BioNTech has announced a new mRNA therapeutic vaccine that has shown early success in treating colorectal cancer.
Early results from clinical trials show that the new mRNA vaccine to treat pancreatic cancer, cevumeran, showed significant promise.
Project Veritas claims that Pfizer COVID-19 research employed some unethical studies to sell more vaccines. It is completely false.